Litcius/Paper detail

ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF

Michael T. Durheim, Anna‐Maria Hoffmann‐Vold, Tomas Eagan, Arnt‐Ove Hovden, May Brit Lund, Gisle Bjerke, Surinder S. Birring, Trygve Müller Jonassen, Odd Erik Johansen, Tone Sjåheim

2020BMJ Open Respiratory Research19 citationsDOIOpen Access PDF

Abstract

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease (SSc-ILD) are fibrotic ILDs with divergent disease populations. Little is known about health-related quality of life (HRQL) in SSc-ILD relative to IPF. METHODS: We used the Kings Brief Interstitial Lung Disease Questionnaire (K-BILD) to compare HRQL in a cross-sectional study of 57 patients with IPF and 29 patients with SSc-ILD. Analysis of covariance was used to adjust for age, gender and lung function. RESULTS: The unadjusted mean K-BILD score was 63.1 (95% CI 57.1 to 69.1) among patients with SSc-ILD, as compared with 54.7 (51.8-57.5) among those with IPF (p=0.005). However, this difference in HRQL was attenuated after adjustment for age, gender and lung function. In a multivariable model, only forced vital capacity was associated with K-BILD scores. K-BILD scores were correlated with both forced vital capacity and with other relevant HRQL measures, regardless of ILD diagnosis. DISCUSSION: Patients with SSc-ILD may have better ILD-specific quality of life than patients with IPF, but this difference appears to be driven primarily by better lung function. These results underscore the impact of lung function on HRQL in fibrotic ILD and the utility of K-BILD to assess HRQL in SSc-ILD.

Topics & Concepts

MedicineInterstitial lung diseaseVital capacityIdiopathic pulmonary fibrosisQuality of life (healthcare)Internal medicinePulmonary function testingLung functionLungScleroderma (fungus)Physical therapyPathologyDiffusing capacityNursingInoculationSystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisInflammatory Myopathies and Dermatomyositis